Monitoring Enoxaparin with Antifactor Xa Levels in Obese Patients

E-ISSN： 1875-9114|35|11|1007-1015

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.11, 2015-11, pp. : 1007-1015

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 41, Iss. 5, 2016-10 ,pp. : 499-502

John Wiley & Sons Inc

Access to resources Recommend Favorite

Retrospective cohort study comparing activated partial thromboplastin time versus anti‐factor Xa activity nomograms for therapeutic unfractionated heparin monitoring in pediatrics

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 5, 2015-05 ,pp. : 788-794

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apelin levels in endometrial cancer

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 2, 2015-02 ,pp. : 294-300

John Wiley & Sons Inc

Access to resources Recommend Favorite

Monitoring Digoxin Levels in a Group of Nursing Home Patients

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 30, Iss. 5, 1982-05 ,pp. : 360-360

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia

By Nakou E. S. Filippatos T. D. Georgoula M. Kiortsis D. N. Tselepis A. D. Mikhailidis D. P. Elisaf M. S.

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1919-1929

Informa Healthcare

Access to resources Recommend Favorite